Granted Patent
B2
US 12,599,622 · App. 17/983,999 · Granted Apr 14, 2026
Compounds to modulate intestinal absorption of nutrients
Inventors:
Jeffrey M. Karp (Brookline, MA); Yuhan Lee (Cambridge, MA); Ali Tavakkoli (Boston, MA); Tarawatie E. Deelman (Boston, MA)
Assignee:
The Brigham and Women's Hospital, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
This disclosure relates to compositions including formulated sucralfate or other aluminum-crosslinked sulfated agents for the modulation of nutrient absorption through the intestinal lining as well as methods for the manufacture of and the use of these compounds for treating disorders requiring a modulation of certain nutrients to the body including diabetes type II and clinical obesity.
Claims (10)
1 . A composition formulated for oral administration to a subject, the composition comprising an aluminum cross-linked sulfated agent comprising sucralfate reacted with hydrochloric acid to form an acidified aluminum cross-linked sulfated agent, wherein the composition is in the form of a capsule or a tablet, wherein the capsule or tablet includes an enteric coating formulated to release the acidified aluminum cross-linked sulfated agent in at least a portion of the subject's gastrointestinal tract, and wherein an aluminum/sulfate ratio in the composition is greater than or equal to 1.27 and less than or equal to 1.83.
2 . The composition of claim 1 , wherein the acidified aluminum cross-linked sulfated agent is in a dry particulate form.
3 . The composition of claim 2 , wherein the composition comprises particles having a size ranging from about 0.1 μm to about 500 μm.
4 . The composition of claim 1 , wherein the composition further comprises a carrier.
5 . The composition of claim 4 , wherein the carrier comprises lactose, corn starch, silicon oxide, magnesium stearate, cellulose, or sodium lauryl sulfate.
6 . The composition of claim 1 , wherein the composition further comprises a particle stabilizer, a humectant, or both a particle stabilizer and a humectant.
7 . The composition of claim 1 , wherein the composition further comprises a drug or antimicrobial agent.
8 . The composition of claim 1 , wherein the composition further comprises a diabetic therapeutic agent.
9 . A method of treating a subject, the method comprising administering the composition of claim 1 to the subject, wherein the composition forms a mucoadhesive coating on mucosa of at least a portion of the subject's duodenum or jejunum.
10 . The method of claim 9 , wherein the subject has type II diabetes, obesity, insulin resistance, hyperlipidemia, or hypertension.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jan 5, 2023
From: KARP, JEFFREY M.; LEE, YUHAN; TAVAKKOLI, ALI; DEELMAN, TARAWATIE E.
To: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
Reel/Frame 062279/0918 →
Continuity (4)
Continuation
14776594
Provisional Application
61794362
· Mar 15, 2013
References Cited (96)
US 3432489A
· Nitta et al.
· 1969
[cited by applicant]
US 4522811A
· Eppstein et al.
· 1985
[cited by applicant]
US 4866856A
· Feeley
· 1989
[cited by applicant]
US 4885281A
· Hanstein et al.
· 1989
[cited by applicant]
US 5013557A
· Tai
· 1991
[cited by applicant]
US 5246697A
· Conte et al.
· 1993
[cited by applicant]
US 5294434A
· King et al.
· 1994
[cited by applicant]
US 5321013A
· Zagnoli et al.
· 1994
[cited by applicant]
US 5464828A
· Katayama et al.
· 1995
[cited by applicant]
US 5563258A
· Ochi et al.
· 1996
[cited by applicant]
US 5595977A
· Dyrsting et al.
· 1997
[cited by applicant]
US 5661137A
· Zagnoli
· 1997
[cited by applicant]
US 5718923A
· Matsuda et al.
· 1998
[cited by applicant]
US 5968906A
· Kashimura et al.
· 1999
[cited by applicant]
US 6319518B1
· Lee et al.
· 2001
[cited by applicant]
US 6391294B1
· Dettmar et al.
· 2002
[cited by applicant]
US 6391860B1
· McGrath
· 2002
[cited by applicant]
US 6555137B1
· Yamazaki et al.
· 2003
[cited by applicant]
US 6773722B2
· Zagnoli et al.
· 2004
[cited by applicant]
US 20020068088A1
· Gruber
· 2002
[cited by examiner]
US 20070190139A1
· Zerbe et al.
· 2007
[cited by applicant]
US 20090196896A1
· Patton et al.
· 2009
[cited by applicant]
US 20100172967A1
· Nemoto et al.
· 2010
[cited by applicant]
US 20110021455A1
· Chesnoy et al.
· 2011
[cited by applicant]
US 20110229556A1
· Irvine et al.
· 2011
[cited by applicant]
US 20120039981A1
· Pedersen et al.
· 2012
[cited by applicant]
US 20130274209A1
· Colombo
· 2013
[cited by applicant]
CA 2067070
· 1992
[cited by applicant]
EP 0511703
· 1992
[cited by applicant]
EP 0245855
· 1993
[cited by applicant]
EP 0437406
· 1993
[cited by applicant]
EP 2482822
· 2012
[cited by applicant]
RU 2422133
· 2011
[cited by applicant]
WO WO1989005645
· 1989
[cited by applicant]
WO WO2011041509
· 2011
[cited by applicant]
WO WO2014151565
· 2014
[cited by applicant]
WO WO2017053970
· 2017
[cited by applicant]
EP Extended Search Report in European Appln. No. 19932383.3, dated Apr. 11, 2023, 10 pages.
[cited by applicant]
Lee et al., “Therapeutic luminal coating of the intestine,” Nature Materials, Sep. 1, 2018, 17(9):834-42.
[cited by applicant]
Beheshti et al., “Comparison of topical sucralfate and silver sulfadiazine cream in second degree burns in rats,” Adv Clin Exp Med, 2013, 22: 481-487.
[cited by applicant]
chemicalprocessing.com [online]. “Marion Mixers: Comparing Microwave to Conventional Heating and Drying Systems,” dated Jun. 12, 2015 [retrieved on Nov. 22, 2016]. Retrieved from the Internet <URL:http://www.chemicalpro…
[cited by applicant]
Couzin, “Bypassing Medicine to Treat Diabetes,” Science, 2008, 320: 438-440.
[cited by applicant]
Cummings and Flum, “Gastrointestinal Surgery as a Treatment for Diabetes,” J. Am. Med. Assoc., 2008, 299: 341-343.
[cited by applicant]
De Kruif et al., “Complex coacervation of proteins and anionic polysaccharides,” Current Opinion in Colloid & Interface Science, Dec. 1, 2004, 9(5):340-9.
[cited by applicant]
en.wikipedia.org [online]. “Freeze-drying,” dated Sep. 18, 2015 [retrieved on Nov. 22, 2016], Retrieved from the Internet <URL: https://en.wikipedia.org/w/index.php?title=Freezedrying&oldid=681682674> 7 pages.
[cited by applicant]
en.wikipedia.org [online]. “Coacervate,” dated May 20, 2015 [retrieved on Nov. 22, 2016]. Retrieved from the Internet <URL:https://en.wikipedia.org/w/index.php?title=Coacervate&oldid=663181907> 2 pages.
[cited by applicant]
en.wikipedia.org [online]. “List of water-miscible solvents,” dated Mar. 31, 2015[retrieved on Nov. 22, 2016]. Retrieved from the Internet <URL:https://en.wikipedia.org/w/index.php?title=list_ofwater-miscible_solvents&o…
[cited by applicant]
en.wikipedia.org [online]. “Propylene glycol,” dated Sep. 19, 2015 [retrieved on Nov. 22, 2016]. Retrieved from the Internet <URL:https://en.wik1pedia.org/w/index.php?title=Propylene_glycol&oldid=681710532> 7 pages.
[cited by applicant]
EP Extended European Search Report in Application No. 16849871.5, dated May 7, 2019, 10 pages.
[cited by applicant]
EP Office Action in European Appln. No. 16849871, dated Jun. 24, 2020, 8 pages.
[cited by applicant]
Fuhrmann et al., “Sustained gastrointestinal activity of dendronized polymer-enzyme conjugates,” Nature Chemistry, Jul. 2013, 5(7):582-9.
[cited by applicant]
Gersin et al., “Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates,” Gastrointest. Endosc. 2010, 71: 976-82.
[cited by applicant]
Gupta et al., “Topical Sucralfate Treatment of Anal Fistulotomy Wounds: A Randomized Placebo-Controlled Trial,” Diseases of the Colon & Rectum, 2011, 54: 699-704.
[cited by applicant]
Hem et al., “Form and stability of aluminum hydroxide complexes in dilute solution,” Geological Survey Water-Supply Paper, Jan. 1967, 60 pages.
[cited by applicant]
Higo et al., “A novel evaluation method of gastric mucoadhesive property in vitro and the mucoadhesive mechanism of tetracycline-sucralfate acidic complex for eradication of Helicobacter pylori,” Pharmaceutical Research…
[cited by applicant]
Higo et al., “A Novel Evaluation Method of Gastric Mucoadhesive Property in Vitro and the Mucoadhesive Mechanism of Tetracycline-Sucralfate Acidic Complex for Eradication of Helicobacter pylori,” Pharm. Res, 2004, 21: 4…
[cited by applicant]
Malbert et al., “Duodenal Bulb Control of the Flow Rate of Digesta in the Fasted and Fed Dog,” J. Physiol., 1989, 409:371-384.
[cited by applicant]
Markham et al., “Topical sucralfate for erosive irritant diaper dermatitis,” Archives of Dermatology, 2000, 136: 1199-200.
[cited by applicant]
Nail et al., “Structure of aluminum hydroxide gel I: initial precipitate,” Journal of Pharmaceutical Sciences, Aug. 1976, 65(8):1188-91.
[cited by applicant]
New et al., “Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice,” Diabetic Medicine, 2007, 24: 364-369.
[cited by applicant]
Ochi, “Chemistry of Sucralfate” in Sucralfate: From Basic Science to the Bedside, Chapter 5, 1995, pp. 53 and 55.
[cited by applicant]
PCT International Preliminary Report on Patentability in International Application No. PCT/US2014/26007, dated Sep. 15, 2015, 9 pages.
[cited by applicant]
PCT International Preliminary Report on Patentability in International Application No. PCT/US2016/053781, mailed on Mar. 27, 2018, 8 pages.
[cited by applicant]
PCT International Preliminary Report on Patentability in International Appln. No. PCT/US2019/036423, dated Dec. 14, 2021, 7 pages.
[cited by applicant]
PCT International Search Report and Written Opinion in International Application No. PCT/US2014/26007, dated Jul. 7, 2014, 16 pages.
[cited by applicant]
PCT International Search Report and Written Opinion in International Application No. PCT/US2016/053781, mailed on Jan. 26, 2017, 15 pages.
[cited by applicant]
PCT International Search Report and Written Opinion in International Appln. No. PCT/US2019/036423, dated Aug. 27, 2019, 14 pages.
[cited by applicant]
Pories et al., “Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult-Onset Diabetes Mellitus,” Ann. Surg., 1995, 222: 339-350.
[cited by applicant]
pueschner.com [online]. “Microwave Vacuum Drying for advanced Process Technology,” Oct. 29, 2012 [retrieved on Nov. 22, 2016). Retrieved from the Internet <URL:http://www.pueschner.com/downloads/vacuumdrying.pdf> 8 page…
[cited by applicant]
Ritz et al., “Nephropathy in patients with type 2 diabetes mellitus,” New Engl. J. Med., 1999, 341: 1127-1133.
[cited by applicant]
RU English translation of RU 2422133 01 (Year: 2011).
[cited by applicant]
Rubino et al., “Potential of Surgery for Curing Type 2 Diabetes Mellitus,” Ann. Surg., 2002, 236: 554-559.
[cited by applicant]
Schouten et al., “A multi-center, randomized efficacy study of the EndoBarrier™ Gastrointestinal Liner for pre-surgical weight loss prior to bariatric surgery,” Ann. Surg., 2010, 251(2), 236-243.
[cited by applicant]
Slomiany et al., “Enhancement of the protective qualities of gastric mucus by sucralfate: Role of phosphoinositides,” Am. J. of Med., 1991, 91: 30S-36S.
[cited by applicant]
Tasman-Jones et al., “Sucralfate interactions with gastric mucus,” Am. J. Med., 1989, 86: 5-9.
[cited by applicant]
US Office Action in U.S. Appl. No. 14/776,594, dated Jan. 18, 2017, 12 pages.
[cited by applicant]
US Office Action in U.S. Appl. No. 14/776,594, dated Nov. 28, 2017, 12 pages.
[cited by applicant]
US Office Action in U.S. Appl. No. 14/776,594, dated May 8, 2019, 13 pages.
[cited by applicant]
US Office Action in U.S. Appl. No. 15/763,018, dated Aug. 19, 2020, 29 pages.
[cited by applicant]
Veis et al., “Phase separation in polyelectrolyte systems. I. Complex coacervates of gelatin,” The Journal of Physical Chemistry, Sep. 1960, 64(9):1203-10.
[cited by applicant]
Wang et al., “The polyelectrolyte complex/coacervate continuum,” Macromolecules, May 13, 2014, 47(9):3108-16.
[cited by applicant]
Zelikin et al., “Materials and methods for delivery of biological drugs,” Nature Chemistry, Nov. 2016, 8(11):997-1007.
[cited by applicant]
Zhang et al., “A pH-responsive supramolecular polymer gel as an enteric elastomer for use in gastric devices,” Nature Materials, Oct. 2015, 14(10):1065, 20 pages.
[cited by applicant]
Zuidam et al., “Overview of Microencapsulates for Use in Food Products or Processes and Methods to Make Them in Encapsulation Technologies for Active Food Ingredients and Food Processing,” Chapter 2, 2010, p. 15.
[cited by applicant]
CN Office Action in Chinese Appln. No. 201980099194.6, mailed on Aug. 25, 2023, 18 pages (with English translation).
[cited by applicant]
IN Office Action in Indian Appln. No. 202217001272, mailed on Feb. 1, 2024, 7 pages.
[cited by applicant]
KR Office Action in Korean Appln. No. 10-2022-7000322, mailed on Sep. 19, 2024, 20 pages (with English translation).
[cited by applicant]